|Institution:||Vall d’Hebron University Hospital, Barcelona|
Patricia Pozo-Rosich MD PhD, is a specialist in Neurology.
She is Head of Section of the Neurology Department, Director of Headache and Craniofacial Pain Clinical Unit and the Migraine Adaptive Brain Center at the Vall d’Hebron University Hospital in Barcelona, Spain; Coordinator of the Brain, Mind & Behaviour eCORE and Group Leader and Principal Investigator of the Headache Research Laboratory at the Vall d’Hebron Institute of Research (VHIR), which belongs to the Universitat Autonoma of Barcelona (UAB).
She is the past Coordinator of the Spanish Headache Study Group of the Spanish Neurological Society (cefaleas.sen.es), past member of the Council of the European Headache Federation, past trustee member of the International Headache Society.
She is a member of the Scientific Advisory Board of the Fundación Lilly Spain.
She is the Editor for Headache for Revista de Neurologia, an Associate Editor of Cephalalgia, Headache, Neurologia, Frontiers in Neurology (Headache Medicine) and a member of the Editorial Advisory Board of The Journal of Headache and Pain.
She has edited Guidelines for the Diagnosis and Treatment of Headache, authored original papers and written a book.
Dr Pozo-Rosich’s research focuses on better understanding the pathophysiology of migraine from a multidisciplinary approach using genetics, neuroimaging and electrophysiology. She is a member of the International Headache Genetics Consortium. She has been awarded research grants from the la Caixa Foundation, Fondo de Investigaciones Sanitarias (ISCIII), ERANet Neuron, PERIS grant, FEDER, la Marató TV3 Foundation, International Headache Society, AGAUR, Mutual Medica and, the Migraine Research Foundation; as well as from Allergan/AbbVie, Novartis and Teva Pharmaceuticals.
She has been the principal investigator of more than 40 clinical trials in phases II, III and IV.
She educates neurologists, other physicians and patients with the goal of improving the quality of life of patients suffering from headache and helping reduce the stigma of migraine.
She is the founder and developer of the website in Spanish dedicated to headache www.midolordecabeza.org for patients and physicians which has more than 8,600 registered users and more than 25,000 facebook followers.
Employment: Catalan Health Government – Vall d’Hebron University Hospital
Society Leadership/Board position: Scientific Advisory Board of Lilly Foundation Spain
Professional membership: Sociedad Española Neurologia, American Headache Society
Personal fees: Honoraria as a consultant and participated in advisory boards for AbbVie, Biohaven, Eli Lilly, Lundbeck, Medscape, Novartis, Pfizer, Teva Pharmaceuticals. Medical Education projects with AbbVie, Chiesi, Eli Lilly, Lundbeck, Medscape, Novartis, Teva Pharmaceuticals; Grants: AGAUR, EraNet NEURON, La Caixa Foundation, Instituto Investigación Carlos III, AbbVie, Novartis, Teva Pharmaceuticals (all to research group)
Principal investigator: PI for 50 clinical trials (phase III and IV) with AbbVie, Biohaven, Eli Lilly, Lundbeck, Novartis, Teva Pharmaceuticals
Relationship with scientific journals: Associate Editor for Cephalalgia, Headache, Neurologia, Director for Headache Section of Revista de Neurologia, Advisor for The Journal of Headache and Pain